Clinical significance of detecting serum procalcitonin and high sensitivity c-reactive protein level in hemodialysis patients

Hong Wu,Yuefei Xiao
DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2016.09.010
2016-01-01
Abstract:Objective To investigate the clinical significance of detecting serum procalcitonin (PCT) and high sensitivity C-reactive protein (hs-CRP) in hemodialysis patients. Methods Hs-CRP and serum PCT were detected pre-dialysis in 320 patients with maintenance hemodialysis (MHD) from November 2013, the patients whose hs-CRP>5.00 mg/L were involved in our study. As of December 2014, 169 cases of inflammation were collected, including 110 cases of fistula dialysis, 59 cases of catheter dialysis. After one year’s follow-up, 24 cases were diagnosed local catheter infection, 13 cases were diagnosed catheter-related bacteremia. Hs-CRP and PCT were detected after antibiotic treatment for 0, 3, 7, 14 d in patients with bacteremia. Results Hs-CRP and PCT increased at different degree in all MHD patients, and microinflammation was commonly happened in MHD patients with the rate of 52.81%. Hs-CRP [(49.70±2.02)mg/L] and PCT [(2.96±1.12)ng/ml] in catheter patients were higher than those [(14.78±1.32)mg/L, (0.46±0.19)ng/ml] in fistula group and the differences had statistical significance (P<0.05); PCT levels [(8.29±0.06)ng/ml] were higher in catheter-related bacteremia group compared with local catheter infection group [(0.96±0.09)ng/ml] and the difference had statistical significance. The sensitivity and specificity of catheter-related bacteremia diagnosis were improved to 94.93% and 95.20%respectively while PCT combined with hs-CRP detection were applied. Conclusions The prevalence of&nbsp;hemodialysis is more than 50% of the MHD patients, and the inflammatory is more severe in patients with internal fistula. PCT can well identify the extent of catheter infection, earlier reflect antibiotic drug efficacy. Combined detection of PCT and hs-CRP can improve the sensitivity and specificity for the diagnosis of bacteremia, which is a good clinical guidance for inflammation monitoring and vascular access selection and maintenance in MHD patients.
What problem does this paper attempt to address?